Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Morphine sulfate
Drug ID BADD_D01499
Description Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805.[A176035] It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse.[A176050] Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as [codeine], [fentanyl], [methadone], [hydrocodone], [hydromorphone], [meperidine], and [oxycodone]. Morphine was granted FDA approval in 1941.[L12114]
Indications and Usage Morphine is used for the management of chronic, moderate to severe pain.[A176050] Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.[L5728]
Marketing Status approved; investigational
ATC Code N02AA01
DrugBank ID DB00295
KEGG ID D00842
MeSH ID D009020
PubChem ID 16051935
TTD Drug ID D0WE3O
NDC Product Code 0641-6126; 76045-007; 0832-0233; 0904-6560; 51552-0678; 40032-543; 42689-008; 42858-760; 42858-811; 51862-186; 63323-451; 67296-1753; 67877-671; 0409-1890; 0054-0236; 76045-005; 76045-006; 76045-008; 49812-0149; 0115-1277; 0115-1282; 42858-515; 42858-803; 42858-805; 43386-543; 0228-3117; 0228-4270; 55700-825; 63304-758; 63629-2538; 63629-4175; 0409-1134; 0054-0404; 0641-6039; 0406-1521; 62991-1403; 81371-1062; 27808-082; 42858-804; 42858-900; 50383-965; 51862-185; 51862-615; 55700-824; 63629-3789; 67877-670; 0406-8315; 0574-7112; 63629-1088; 63629-2301; 63629-2537; 66794-160; 0409-3815; 0574-7114; 0574-7116; 71335-0239; 75826-130; 76329-1911; 76329-1912; 0832-0273; 38779-0673; 40032-541; 42858-810; 43386-542; 0228-4323; 63304-450; 63629-8459; 63629-8460; 0406-8330; 0406-8390; 68084-158; 0409-1891; 0409-1892; 0409-3814; 0054-0238; 70166-101; 0641-6019; 75826-131; 76045-004; 0832-0230; 0406-1516; 17856-0517; 0115-1279; 0121-0825; 42689-005; 42858-801; 51862-187; 0228-3093; 55700-905; 63629-2536; 63629-4514; 63629-8505; 67296-1561; 0054-0517; 71335-0676; 71335-0707; 0641-6125; 51634-0969; 67509-004; 0115-1280; 0115-1479; 40032-540; 42689-010; 43386-540; 43386-544; 63323-454; 63323-458; 63629-4484; 0406-8320; 51927-1000; 69988-0036; 0115-1278; 0121-0904; 40032-544; 42689-006; 0228-4311; 63304-452; 63629-1087; 63629-1089; 63629-1090; 63629-4515; 66794-162; 0406-8003; 0574-7110; 71335-9662; 0641-6127; 0832-0225; 42858-802; 0228-3091; 0228-3092; 0228-4271; 0228-4347; 60687-617; 61919-413; 63304-453; 63629-2535; 0406-8380; 68084-157; 0409-1893; 71335-0736; 72572-440; 0641-6020; 75826-129; 0832-0226; 0832-0274; 0904-6558; 49452-0028; 0115-1281; 40032-542; 42689-007; 42858-631; 51862-617; 63304-451; 63323-452; 63323-455; 63629-1091; 63629-2302; 63629-4483; 67296-1522; 68094-001; 68094-045; 68094-056; 0054-0235; 0054-0237; 0641-6040; 0832-0227; 0832-0228; 0832-0229; 0904-6557; 0904-6559; 82393-120; 42689-009; 42858-799; 42858-812; 43386-541; 49999-848; 51862-188; 0228-3090; 0228-3116; 55700-349
UNII X3P646A2J0
Synonyms Morphine | Morphia | Morphine Chloride | Chloride, Morphine | Morphine Sulfate | Sulfate, Morphine | SDZ 202-250 | SDZ 202 250 | SDZ 202250 | SDZ202-250 | SDZ202 250 | SDZ202250 | Morphine Sulfate (2:1), Pentahydrate | MS Contin | Contin, MS | Oramorph SR | Duramorph | Morphine Sulfate (2:1), Anhydrous
Chemical Information
Molecular Formula C34H40N2O10S
CAS Registry Number 64-31-3
SMILES CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O.CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C 4)O.OS(=O)(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Disturbance in attention17.03.03.001; 19.21.02.002--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Drug withdrawal syndrome08.06.02.004; 19.07.06.013---
Dry mouth07.06.01.002--
Dysgeusia07.14.03.001; 17.02.07.003--
Dyskinesia17.01.02.006--
Dyspepsia07.01.02.001--
Dysphoria19.04.02.004---
Dyspnoea02.11.05.003; 22.02.01.004--
Dysuria20.02.02.002--
Euphoric mood19.04.02.006--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014---
Feeling jittery08.01.09.016---
Flatulence07.01.04.002--
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypertension24.08.02.001--
Hypotension24.06.03.002--
Ileus07.13.01.001--
Insomnia17.15.03.002; 19.02.01.002--
Intestinal obstruction07.13.01.002---
Intracranial pressure increased17.07.02.002---
Irritability08.01.03.011; 19.04.02.013--
Laryngospasm22.04.02.002--
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.004--
Libido decreased19.08.03.001; 21.03.02.005--
Malaise08.01.01.003--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages